Cellular Biomedicine Group Inc (NASDAQ:CBMG)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - CBMG

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - CBMG

  • Market Cap$355.040m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS15117P1021

Company Profile

Cellular Biomedicine Group Inc is a biotechnology company focused on the development of proprietary cell therapies for the treatment of cancer and degenerative diseases. The company has two major cell platforms: immune cell therapy for treating a broad range of cancers using cancer vaccines, Chimeric Antigen Receptor T-cell technologies, and anti-PD-1 technologies; and human-adipose-derived mesenchymal progenitor cells for treatment of joint and autoimmune diseases. The immuno-oncology and stem cell research team is based in both China and the United States.Cellular Biomedicine Group Inc is a part of the healthcare sector. It is engaged in the development of new treatments for cancerous and degenerative diseases.

Latest CBMG news

Currently there for this company. Visit our news hub for other news .